Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Qianjiang Yongan Pharmaceutical Co., Ltd.
—
Qianjiang Yongan Pharmaceutical Co., Ltd. is led by CEO Ren Gui Hong, employs 912 people, headquartered in Qianjiang, CN, publicly traded since 2010.
Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) stock trades at $11.51 with a market capitalization of $3.97B. The stock is valued at a price-to-earnings (P/E) ratio of 74.89, price-to-book of 1.95, price-to-sales of 4.06. Over the past 52 weeks the stock has ranged between $9.82 and $18.10, and currently trades 36.4% below its 52-week high. It pays a dividend yielding 0.74%.
On profitability, Qianjiang Yongan Pharmaceutical Co., Ltd. generates a return on equity (ROE) of 2.07%, an operating margin of 14.49%, a net profit margin of 5.45%.
Official website: www.chinataurine.com
Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) — frequently asked questions
What is Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) stock price today?
Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) is currently trading at $11.51, down 2.7% today.
What is 002365.SZ P/E ratio?
Qianjiang Yongan Pharmaceutical Co., Ltd.'s P/E ratio is 74.89. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.
What is 002365.SZ return on equity (ROE)?
Qianjiang Yongan Pharmaceutical Co., Ltd.'s return on equity (ROE) is 2.07%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Qianjiang Yongan Pharmaceutical Co., Ltd.'s market cap?
Qianjiang Yongan Pharmaceutical Co., Ltd. has a market capitalization of $3.97B.
Does 002365.SZ pay a dividend?
Yes. Qianjiang Yongan Pharmaceutical Co., Ltd. currently yields 0.74%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 002365.SZ carry?
Qianjiang Yongan Pharmaceutical Co., Ltd. has a debt-to-equity ratio of 0.00. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 002365.SZ's profit margin?
Qianjiang Yongan Pharmaceutical Co., Ltd. reports a net profit margin of 5.45% — the share of revenue left after every cost, including tax and interest.
What sector is 002365.SZ in?
Qianjiang Yongan Pharmaceutical Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 002365.SZ listed on?
Qianjiang Yongan Pharmaceutical Co., Ltd. trades on SHZ under the ticker 002365.SZ.
What is 002365.SZ's 52-week range?
Over the last year Qianjiang Yongan Pharmaceutical Co., Ltd. has traded between $9.82 and $18.10.
Related — Stocks
Popular Stocks
Screens 002365.SZ currently matches
On the figures above, Qianjiang Yongan Pharmaceutical Co., Ltd. passes the filters for 9 of our ready-made screens, among them Low Debt Stocks, Debt Free Stocks Under $100, High PE Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.